Recent breakthrough research on semaglutide shows promise in reducing alcohol consumption by up to 40%, while smartphone-based interventions are proving effective in supporting medication adherence and behavioral change
This study marks the first examination of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), for treating HS
N.HuangC
Leer ms Dexcom, Inc., lder en medidores continuos de glucosa (MCG), ha anunciado el lanzamiento de Stelo,

NICE-recommended weight management strategies include: Dietary intervention aiming for a 600 kcal/day deficit through reduced portion sizes, limiting energy-dense foods, and increasing fruit and vegetable consumption Physical activity building up to 150300 minutes of moderate-intensity aerobic activity weekly, plus muscle-strengthening activities on at least two days weekly, in line with UK Chief Medical Officers' guidelines [10] Behavioural approaches including self-monitoring, goal-setting, and addressing emotional eating patterns Commercial weight management programmes such as those meeting NICE quality standards (QS127) Very-low-calorie diets in specific circumstances, under clinical supervision and for limited periods For patients with a BMI 30 kg/m (or 27.5 kg/m in those of South Asian, Chinese, or other Asian family origin) who have not achieved adequate weight loss through lifestyle measures alone, pharmacological interventions may be considered

Preclinical Toxicology Animal studies and in vitro testing have not identified mutagenic (cancer-causing) or genotoxic (DNA-damaging) effects of BPC-157